Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Patients:
- Men aged 65 or older
- People who have been diagnosed with localised prostate cancer (cancer that has not spread beyond the prostate)
- People who have been on an active surveillance program for their prostate cancer for 12 months or more
- People who are fluent in English
Caregivers:
- People aged 18 or older who are fluent in English and are involved in caring for an eligible patient, such as a partner, close friend, family member, or companion
Clinicians:
- Healthcare professionals aged 18 or older who are fluent in English and provide clinical care for prostate cancer patients — for example, oncologists, urologists, radiation oncologists, nurse practitioners, or physician assistants
Who may not be able to join:
Patients:
- People who are currently receiving treatment for another cancer, whether a new cancer or a returning one
Caregivers:
- No additional exclusion criteria listed for caregivers
Clinicians:
- No additional exclusion criteria listed for clinicians
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lisa Lowenstein, MD, M.D. Anderson Cancer Center
Phone: 713-563-0020
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The Ottawa Acceptability Scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.